CR7497A - Determinados compuestos de 1-(d-ciclopropilglicinil)-4 (piperidin-4-il) piperazina como inhibidores del factor xa de serina proteasa - Google Patents

Determinados compuestos de 1-(d-ciclopropilglicinil)-4 (piperidin-4-il) piperazina como inhibidores del factor xa de serina proteasa

Info

Publication number
CR7497A
CR7497A CR7497A CR7497A CR7497A CR 7497 A CR7497 A CR 7497A CR 7497 A CR7497 A CR 7497A CR 7497 A CR7497 A CR 7497A CR 7497 A CR7497 A CR 7497A
Authority
CR
Costa Rica
Prior art keywords
factor
inhibitors
ciclopropilglicinil
piperidin
piperazine
Prior art date
Application number
CR7497A
Other languages
English (en)
Inventor
Robert Wiley Michael
Lowell Engel Gary
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CR7497A publication Critical patent/CR7497A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/52—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Los compuestos de formula (I) en la que R representa un atomo de hidrogeno o un atomo de fluor, o una sal farmaceuticamente aceptable de los mismos son inhibidores del factor Xa utiles en el tratamiento de trastornos tromboticos.
CR7497A 2002-04-01 2004-09-24 Determinados compuestos de 1-(d-ciclopropilglicinil)-4 (piperidin-4-il) piperazina como inhibidores del factor xa de serina proteasa CR7497A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36852302P 2002-04-01 2002-04-01

Publications (1)

Publication Number Publication Date
CR7497A true CR7497A (es) 2005-01-17

Family

ID=28791889

Family Applications (1)

Application Number Title Priority Date Filing Date
CR7497A CR7497A (es) 2002-04-01 2004-09-24 Determinados compuestos de 1-(d-ciclopropilglicinil)-4 (piperidin-4-il) piperazina como inhibidores del factor xa de serina proteasa

Country Status (25)

Country Link
US (1) US7166606B2 (es)
EP (1) EP1492767B1 (es)
JP (1) JP2005531529A (es)
KR (1) KR20040094892A (es)
CN (1) CN1288135C (es)
AT (1) ATE303990T1 (es)
AU (1) AU2003218147A1 (es)
BR (1) BR0308870A (es)
CA (1) CA2478340A1 (es)
CR (1) CR7497A (es)
DE (1) DE60301569T2 (es)
DK (1) DK1492767T3 (es)
EA (1) EA007300B1 (es)
EC (1) ECSP045329A (es)
ES (1) ES2248737T3 (es)
HK (1) HK1070363A1 (es)
HR (1) HRP20040900B1 (es)
IL (1) IL164018A0 (es)
MX (1) MXPA04009640A (es)
NO (1) NO20044688L (es)
NZ (1) NZ535402A (es)
PL (1) PL373066A1 (es)
UA (1) UA76849C2 (es)
WO (1) WO2003084929A1 (es)
ZA (1) ZA200407418B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6834308B1 (en) 2000-02-17 2004-12-21 Audible Magic Corporation Method and apparatus for identifying media content presented on a media playing device
EP1490767B1 (en) 2001-04-05 2014-06-11 Audible Magic Corporation Copyright detection and protection system and method
US8972481B2 (en) 2001-07-20 2015-03-03 Audible Magic, Inc. Playlist generation method and apparatus
DE102014108210A1 (de) 2014-06-11 2015-12-17 Dietrich Gulba Rodentizid
US11014920B2 (en) 2016-11-18 2021-05-25 Merck Sharp & Dohme Corp. Factor XIIa inhibitors
EP4070658A1 (de) 2021-04-06 2022-10-12 BIORoxx GmbH Verwendung von blutgerinnungshemmenden verbindungen als rodentizide

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1012166B1 (en) 1997-08-29 2003-10-29 Tularik Limited 1-amino-7-isoquinoline derivatives as serine protease inhibitors
EP1192132B1 (en) 1999-06-14 2005-09-07 Eli Lilly And Company Serine protease inhibitors
EP1192135A2 (en) 1999-06-14 2002-04-03 Eli Lilly And Company Serine protease inhibitors
GB0030304D0 (en) * 2000-12-13 2001-01-24 Lilly Co Eli Compounds
GB0030305D0 (en) 2000-12-13 2001-01-24 Lilly Co Eli Compounds
GB0030306D0 (en) 2000-12-13 2001-01-24 Lilly Co Eli Compounds
GB0030303D0 (en) 2000-12-13 2001-01-24 Lilly Co Eli Compounds
TWI257389B (en) 2001-06-12 2006-07-01 Lilly Co Eli Pharmaceutical compound
US7265121B2 (en) * 2001-07-26 2007-09-04 Eli Lilly And Company Chemical compounds

Also Published As

Publication number Publication date
NO20044688L (no) 2004-10-29
HRP20040900A2 (en) 2004-12-31
WO2003084929A8 (en) 2004-05-21
CA2478340A1 (en) 2003-10-16
JP2005531529A (ja) 2005-10-20
HRP20040900B1 (en) 2006-02-28
DK1492767T3 (da) 2005-11-28
NZ535402A (en) 2006-02-24
DE60301569T2 (de) 2006-06-14
EP1492767B1 (en) 2005-09-07
ATE303990T1 (de) 2005-09-15
PL373066A1 (en) 2005-08-08
BR0308870A (pt) 2005-01-04
KR20040094892A (ko) 2004-11-10
EA200401290A1 (ru) 2005-02-24
EA007300B1 (ru) 2006-08-25
WO2003084929A1 (en) 2003-10-16
CN1642914A (zh) 2005-07-20
UA76849C2 (uk) 2006-09-15
MXPA04009640A (es) 2005-01-11
AU2003218147A1 (en) 2003-10-20
ES2248737T3 (es) 2006-03-16
DE60301569D1 (de) 2005-10-13
ZA200407418B (en) 2005-09-15
CN1288135C (zh) 2006-12-06
US20050096328A1 (en) 2005-05-05
ECSP045329A (es) 2004-11-26
HK1070363A1 (en) 2005-06-17
EP1492767A1 (en) 2005-01-05
IL164018A0 (en) 2005-12-18
US7166606B2 (en) 2007-01-23

Similar Documents

Publication Publication Date Title
EA200701467A1 (ru) Пирролидиновые ингибиторы иап (ингибиторов апоптоза)
IS7718A (is) Pýrrólídíndíónútskipt píperídín-þalasón sem PDE4 tálmar
EA200600223A1 (ru) Замещённый 2-аминотетралины для лечения депрессии
IS6902A (is) N-setin heterósýklísk NMDA/NR2B mótlyf sem ekki eru arýl
MX2007000505A (es) Derivados de oxindol sustituidos y medicamentos que contienen los mismos.
DE602005012634D1 (en) Arylsulfonylnaphthalinderivate als 5ht2a-antagonisten
DE602006011752D1 (de) Als antikoagulationsmittel geeignete phenylglycinamid- und pyridylglycinamidderivate
PE20030061A1 (es) 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
BRPI0409276A (pt) derivados de piperazina inibidores de renina
HK1070363A1 (en) Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serineprotease factor xa
ATE359283T1 (de) Substituierte pyrazinonverbindungen zur behandlung von entzündungen
DE602004018811D1 (de) Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren
DE60224805D1 (de) 1-glycinyl-4-(1-methylpiperidin-4-yl)piperazine un
TW200603806A (en) Pharmaceutical compound
NO20064410L (no) Fremgangsmate for fremstilling av tryptaseinhibitorer
ATE348803T1 (de) Tryptase-inhibitoren
DK1358182T3 (da) Diazocin-derivater og anvendelsen deraf som tryptase-inhibitorer
ATE364037T1 (de) Tryptasehemmer
TW200519071A (en) 3-aryl-2-cyano-3-hydroxy-acrylic acid derivatives
SE0200119D0 (sv) Novel compounds